KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Receivables (2016 - 2026)

Labcorp Holdings' Receivables history spans 18 years, with the latest figure at $2.5 billion for Q1 2026.

  • On a quarterly basis, Receivables rose 7.74% to $2.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.5 billion, a 7.74% increase, with the full-year FY2025 number at $2.3 billion, up 7.81% from a year prior.
  • Receivables hit $2.5 billion in Q1 2026 for Labcorp Holdings, up from $2.3 billion in the prior quarter.
  • Over the last five years, Receivables for LH hit a ceiling of $3.0 billion in Q1 2023 and a floor of $1.3 billion in Q4 2022.
  • Historically, Receivables has averaged $2.3 billion across 5 years, with a median of $2.3 billion in 2025.
  • Biggest five-year swings in Receivables: tumbled 57.74% in 2022 and later surged 66.74% in 2023.
  • Tracing LH's Receivables over 5 years: stood at $1.3 billion in 2022, then surged by 66.74% to $2.1 billion in 2023, then decreased by 0.08% to $2.1 billion in 2024, then rose by 7.81% to $2.3 billion in 2025, then increased by 8.4% to $2.5 billion in 2026.
  • Business Quant data shows Receivables for LH at $2.5 billion in Q1 2026, $2.3 billion in Q4 2025, and $2.3 billion in Q3 2025.